The utility of molecular testing in colorectal cancer: The promise needs progress

Nilofer S. Azad; Luis A. Diaz

The utility of molecular testing in colorectal cancer: The promise needs progress

Nilofer S. Azad, Luis A. Diaz

School of Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Molecularly profiling colorectal cancer has opened many potential opportunities for the use of this information in therapeutic decision-making. However, at present, only RAS testing in the metastatic setting has a definitive place in the decision-making paradigm.

Original language	English (US)
Journal	ONCOLOGY (United States)
Volume	28
Issue number	2
State	Published - Feb 15 2014

ASJC Scopus subject areas

Oncology
Cancer Research

Cite this

@article{7e052d1c2cc64b25a0e87406727bddac,

title = "The utility of molecular testing in colorectal cancer: The promise needs progress",

abstract = "Molecularly profiling colorectal cancer has opened many potential opportunities for the use of this information in therapeutic decision-making. However, at present, only RAS testing in the metastatic setting has a definitive place in the decision-making paradigm.",

author = "Azad, {Nilofer S.} and Diaz, {Luis A.}",

year = "2014",

month = feb,

day = "15",

language = "English (US)",

volume = "28",

journal = "ONCOLOGY (United States)",

issn = "0890-9091",

publisher = "UBM Medica Healthcare Publications",

number = "2",

}

TY - JOUR

T1 - The utility of molecular testing in colorectal cancer

T2 - The promise needs progress

AU - Azad, Nilofer S.

AU - Diaz, Luis A.

PY - 2014/2/15

Y1 - 2014/2/15

N2 - Molecularly profiling colorectal cancer has opened many potential opportunities for the use of this information in therapeutic decision-making. However, at present, only RAS testing in the metastatic setting has a definitive place in the decision-making paradigm.

AB - Molecularly profiling colorectal cancer has opened many potential opportunities for the use of this information in therapeutic decision-making. However, at present, only RAS testing in the metastatic setting has a definitive place in the decision-making paradigm.

UR - http://www.scopus.com/inward/record.url?scp=84896350441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896350441&partnerID=8YFLogxK

M3 - Article

C2 - 24701698

AN - SCOPUS:84896350441

SN - 0890-9091

VL - 28

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

IS - 2

ER -

The utility of molecular testing in colorectal cancer: The promise needs progress

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this